All three major US stock indexes were down after midday trading Thursday, following President Donald Trump's signing of a funding bill into law late Wednesday that ended the longest federal government shutdown in US history.

In company news, Walt Disney (DIS) reported fiscal Q4 adjusted earnings Thursday of $1.11 per diluted share, down from $1.14 a year earlier but above the FactSet consensus analyst estimate of $1.05. Fiscal Q4 revenue was $22.46 billion, down from $22.57 billion a year ago and below the FactSet consensus of $22.76 billion. For fiscal 2026, the company said it expects double-digit adjusted EPS growth from fiscal 2025. Disney shares were down 8.3% after midday.

Verizon Communications (VZ) plans to reduce its workforce by about 15,000 roles, the largest number of job cuts ever implemented by the carrier, The Wall Street Journal reported Thursday, citing people familiar with the matter. Verizon shares were up 1.4%.

Sealed Air (SEE) is in talks regarding a potential takeover by Clayton Dubilier & Rice, The Wall Street Journal reported late Wednesday, citing sources. Sealed Air shares were up nearly 19%.

Firefly Aerospace (FLY) reported a Q3 net loss late Wednesday of $1.50 per diluted share, narrowing from a loss of $3.57 a year earlier, and compared with the FactSet consensus estimate of a loss of $0.41. Third-quarter revenue was $30.8 million, up from $22.4 million a year ago and above the FactSet consensus of $27.7 million. For fiscal 2025, the company said it now expects revenue to be between $150 million and $158 million, up from its previous guidance range of $133 million to $145 million and above the FactSet consensus of $135.5 million. Firefly shares were up 19%.

Brookfield (BN) reported Q3 distributable earnings Thursday of $0.63 per share, up from $0.56 a year earlier and above the FactSet consensus of $0.57. Third-quarter revenue was $18.92 billion, down from $20.62 billion a year ago. Brookfield shares were down 7.2%.

Pfizer (PFE) said Thursday it has completed its acquisition of Metsera (MTSR) for about $7 billion in cash plus a contingent value right of up to $20.65 per share tied to the achievement of three specified clinical and regulatory milestones. Pfizer shares rose 1.1%, while Metsera fell 0.9%.

Price: 106.85, Change: -9.80, Percent Change: -8.40